[Controlled clinical experiments as a scientific basis for neoplasm therapy]

Guidelines for reporting results of quality of life assessments in clinical trials.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·1996

Validation of the clinical predictive values of the in vitro phase II clonogenic assay in cancer of the breast and ovary.

American journal of clinical oncology·1987

Phase I trials of single agents in adult solid tumours: preclinical and clinical aspects.

Drugs under experimental and clinical research·1986

Predictive tests for the response to cancer chemotherapy: limitations related to the prediction of rare events.

Cancer treatment reports·1984

Clinical studies with a THC analog (BRL-4664) in the prevention of cisplatin-induced vomiting.

Journal of clinical pharmacology·1981

Reporting results of cancer treatment.

Cancer·1981

[A case of laryngocele with laryngeal carcinoma].

Nowotwory·1990

[Technique for postoperative irradiation of patients with breast cancer using electron and cobalt beams].

Nowotwory·1990

[Evaluation of results in radical treatment of breast cancer in men].

Nowotwory·1990

[Survival of patients with anaplastic cerebral gliomas treated with a combination of surgery and radiotherapy].

Nowotwory·1990

[Five year survival rate in patients with malignant neoplasms treated for the first time in the Oncology Center, M. Sklodowska-Curie Institute, Cracow Branch in the years 1979-1981].

Nowotwory·1990

[Selected aspects of diagnosis and treatment of prostatic cancer].

Nowotwory·1990

Respiratory Depressant Interactions of Fentanyl and Xylazine and Their Reversal by Naloxone and Yohimbine in Mice.

Neuropharmacology·2026

Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.

JHEP reports : innovation in hepatology·2026

Syringeable hyaluronic acid-based hydrogel co-loaded with Cisplatin and MSA-2 for enhanced ovarian cancer chemoimmunotherapy.

Biomedical materials (Bristol, England)·2026

Yunnan Baiyao inhibits EBV-positive nasopharyngeal carcinoma via ferritinophagy-dependent ferroptosis.

Tissue & cell·2026

Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis.

Journal of biochemical and molecular toxicology·2026

Pathological Response, Tumor Microenvironment Dynamics, and Survival Dissociation after Neoadjuvant Chemoimmunotherapy for Lung Cancer with Rare Histological Subtypes.

Annals of surgical oncology·2026

Related Experiment Videos

[Controlled clinical experiments as a scientific basis for neoplasm therapy]

Related Concept Videos

Guidelines for reporting results of quality of life assessments in clinical trials.

Validation of the clinical predictive values of the in vitro phase II clonogenic assay in cancer of the breast and ovary.

Phase I trials of single agents in adult solid tumours: preclinical and clinical aspects.

Predictive tests for the response to cancer chemotherapy: limitations related to the prediction of rare events.

Clinical studies with a THC analog (BRL-4664) in the prevention of cisplatin-induced vomiting.

Reporting results of cancer treatment.

[A case of laryngocele with laryngeal carcinoma].

[Technique for postoperative irradiation of patients with breast cancer using electron and cobalt beams].

[Evaluation of results in radical treatment of breast cancer in men].

[Survival of patients with anaplastic cerebral gliomas treated with a combination of surgery and radiotherapy].

[Five year survival rate in patients with malignant neoplasms treated for the first time in the Oncology Center, M. Sklodowska-Curie Institute, Cracow Branch in the years 1979-1981].

[Selected aspects of diagnosis and treatment of prostatic cancer].

Respiratory Depressant Interactions of Fentanyl and Xylazine and Their Reversal by Naloxone and Yohimbine in Mice.

Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.

Syringeable hyaluronic acid-based hydrogel co-loaded with Cisplatin and MSA-2 for enhanced ovarian cancer chemoimmunotherapy.

Yunnan Baiyao inhibits EBV-positive nasopharyngeal carcinoma via ferritinophagy-dependent ferroptosis.

Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis.

Pathological Response, Tumor Microenvironment Dynamics, and Survival Dissociation after Neoadjuvant Chemoimmunotherapy for Lung Cancer with Rare Histological Subtypes.

Related Experiment Videos

[Controlled clinical experiments as a scientific basis for neoplasm therapy]

Related Concept Videos

Related Articles